Statistics for Nanobiotix (id:10860 NANO)

Valuation metrics

Market cap

160.44M

Enterprise value

135.48M

Trailing P/E (ttm)

-2.87

Forward P/E

-3.04

PEG ratio

-3.04

Price/Sales (ttm)

3.80

Price/Book (mrq)

Enterprise Value/Revenue

3.21

Enterprise Value/EBITDA

-6.08

Overview

Shares outstanding

47.40M

Float

21.23M

Shares short

% Held by insiders

0.15%

% Held by institutions

0.25%

Average volume (10 days)

62.26K

Average volume (90 days)

Price summary

52-Week low

3.06

52-Week high

7.93

52-Week change

-63.55%

Beta

1.40

50-Day moving average

4.20

200-Day moving average

5.03

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-79.31%

Operating margin

-253.32%

Operational effectiveness

Return on assets

-22.02%

Return on equity

2.15K%

Income statement

Revenue (ttm)

0.98

Revenue per share (ttm)

0.98

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-22,295,000.00

Net income to common (ttm)

-33,473,000.00

Diluted EPS (ttm)

-0.74

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

66.34M

Total cash per share (mrq)

1.40

Total debt (mrq)

49.17M

Total Debt/Equity (mrq)

-26.66

Current ratio (mrq)

142.40%

Book value per share (mrq)

-0.46

Cash flow

Cash flow statement

-1,037,000.00

Levered free cash flow (LFCF)

-4,554,250.00